Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,130.15
(
-0.12%
)
US TECH 100
26,417.00
(
0.44%
)
Dow Jones
48,839.77
(
-0.61%
)
Brent Oil
111.01
(
6.32%
)
Bitcoin
75,612.57
(
-0.96%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122906
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 194204

Wednesday, 05/10/2017 12:31:34 PM

Wednesday, May 10, 2017 12:31:34 PM

Post# of 257465
(INO)—AZN testing Imfinzi/MEDI0457 combo in second-line H&N cancer:

https://finance.yahoo.com/news/inovio-provides-medimmune-launch-combination-120000238.html

MEDI0457 (f/k/a INO-3112) is a cancer vaccine targeting HPV-associated tumors, which AZN licensed in Aug 2015 (#msg-116078700).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today